Jiangsu Vcare PharmaTech Raises RMB 200 Million in Series B Financing Round
China-based Jiangsu Vcare PharmaTech Co. Ltd has reportedly raised over RMB 200 million (USD 28.67...
MindRank AI Receives FDA Approval for MDR-001 Clinical Study in Obesity
Hangzhou-based artificial intelligence (AI)-driven biotech MindRank AI has announced obtaining approval from the US FDA...
Hangzhou Biotest Receives FDA EUA for COVID-19 Antigen Self-Testing Reagent
China-based Hangzhou Biotest Biotech Co., Ltd has announced receiving an Emergency Use Authorization (EUA) from...
Junshi Biosciences Licenses PD-1 Inhibitor Tuoyi to Hikma MENA FZE
China-based Junshi Biosciences (HKG: 1877, SHA: 688180) has announced a licensing agreement with UK-headquartered Hikma...
Shanghai Pharmaceuticals Secures Exclusive Rights for Shionogi’s Ensitrelvir in China
Shanghai Pharmaceuticals (HKG: 2607, SHA: 601607) has announced an import and distribution agreement with Japan-based...
WHO Approves Sinovac’s CoronaVac for Children Aged 3 and Above
The World Health Organization (WHO) has lowered the age limit for Sinovac Biotech Ltd’s (NASDAQ:...
NHSA Orders Investigation into Unreasonable Medical Insurance Restrictions
The National Healthcare Security Administration (NHSA) has released a notification to medical insurance departments across...
Fosun Pharma’s Avatrombopag Receives NMPA Review for Chronic ITP Indication
China-based Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) has announced that another...
Nanjing Pharmaceutical to Acquire Majority Stakes in Three Jiangsu Subsidiaries
China-based Shanghai-listed Nanjing Pharmaceutical Co., Ltd (SHA: 600713) is set to acquire a respective 55%,...
MSD and Kelun Biotech Ink Record-Breaking ADC Deal
Merck, Sharp & Dohme (MSD, NYSE: MRK) has set a new benchmark for the largest...
NMPA and GAC Release Notification on Import and Export Management of Narcotic Drugs
The National Medical Products Administration (NMPA) and the General Administration of Customs (GAC) have released...
Shyndec’s Generic Cytosar-U Gains Marketing Approval in China
China-based Shanghai Shyndec Pharmaceutical Co., Ltd (SHA: 600420) has announced that its generic version of...
Sino Medical Sciences’ NC Rockstar Catheter Approved by US FDA
China-based Sino Medical Sciences Technology Inc. (SHA: 688108) has announced receiving market approval from the...
Antengene Files for Xpovio Approval in Macau, Malaysia, and Thailand
Antengene Corp., Ltd (HKG: 6996) has announced market filings for its Xpovio (selinexor) in Macau,...
Eisai and Biogen Initiate BLA in China for Alzheimer’s Therapy Lecanemab
Japan-based Eisai Co., Ltd (TYO: 4523) and its US co-development partner Biogen Inc. (NASDAQ: BIIB)...
Qitan Tech Raises RMB 700 Million in Series C Financing Led by Meituan
Qitan Tech, a nanopore gene sequencer maker based in Chengdu, has reportedly raised RMB 700...
Kanghong’s Escitalopram Oral Solution Receives NMPA Marketing Approval
China-based Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE: 002773) has announced receiving marketing approval from...
Tonghua Dongbao Receives NMPA Approval for THDBH151 Clinical Study in Gout and Hyperuricemia
China-based Tonghua Dongbao Pharmaceuticals (SHA: 600867) has announced receiving approval from the National Medical Products...
Innovent Biologics Announces Strategic Partnerships to Form Tumor Diagnosis and Treatment Alliance
China-based Innovent Biologics (HKG: 1801) has announced a series of strategic partnerships with compatriot firms...
BioNTech Ships First COVID-19 Vaccine Batches to China
BioNTech is reportedly in the process of shipping the first batches of its COVID-19 vaccines...